Report Detail
Global Exosome Diagnostic and Therapeutics Market Insights, Forecast to 2025
- RnM2716605 |
- 17 June, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Other
Exosomes are cell-derived vesicles that are present in many and perhaps all eukaryotic fluids, including blood, urine, and cultured medium of cell cultures. A sub-type of exosomes, defined as matrix-bound nanovesicles (MBVs), was reported to be present in extracellular matrix (ECM) bioscaffolds (non-fluid). The reported diameter of exosomes is between 30 and 100 nm, which is larger than low-density lipoproteins (LDL) but much smaller than, for example, red blood cells. Exosomes are either released from the cell when multivesicular bodies fuse with the plasma membrane or released directly from the plasma membrane.
The exosome diagnostic and therapeutics market in North America is estimated to reach a high market valuation by end of 2027 and is projected to grow at a significant rate throughout the period of assessment.
The global Exosome Diagnostic and Therapeutics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Exosome Diagnostic and Therapeutics market based on company, product type, end user and key regions.
This report studies the global market size of Exosome Diagnostic and Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Exosome Diagnostic and Therapeutics in these regions.
This research report categorizes the global Exosome Diagnostic and Therapeutics market by top players/brands, region, type and end user. This report also studies the global Exosome Diagnostic and Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Thermo Fisher
NanoSomix
NX PHARMAGEN
Malvern
Capricor
Exosome
Exiqon
System Biosciences
Aegle
AMS
Market size by Product
Instrument
Software
Reagents and Kits
Market size by End User
Hospitals
Cancer Institutes
Diagnostic Centres
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Exosome Diagnostic and Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Exosome Diagnostic and Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Exosome Diagnostic and Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Exosome Diagnostic and Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Exosome Diagnostic and Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Exosome Diagnostic and Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Exosome Diagnostic and Therapeutics Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Exosome Diagnostic and Therapeutics Market Size Growth Rate by Product
- 1.4.2 Instrument
- 1.4.3 Software
- 1.4.4 Reagents and Kits
- 1.5 Market by End User
- 1.5.1 Global Exosome Diagnostic and Therapeutics Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Cancer Institutes
- 1.5.4 Diagnostic Centres
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Exosome Diagnostic and Therapeutics Market Size
- 2.1.1 Global Exosome Diagnostic and Therapeutics Revenue 2014-2025
- 2.1.2 Global Exosome Diagnostic and Therapeutics Sales 2014-2025
- 2.2 Exosome Diagnostic and Therapeutics Growth Rate by Regions
- 2.2.1 Global Exosome Diagnostic and Therapeutics Sales by Regions
- 2.2.2 Global Exosome Diagnostic and Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Exosome Diagnostic and Therapeutics Sales by Manufacturers
- 3.1.1 Exosome Diagnostic and Therapeutics Sales by Manufacturers
- 3.1.2 Exosome Diagnostic and Therapeutics Sales Market Share by Manufacturers
- 3.1.3 Global Exosome Diagnostic and Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Exosome Diagnostic and Therapeutics Revenue by Manufacturers
- 3.2.1 Exosome Diagnostic and Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Exosome Diagnostic and Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.3 Exosome Diagnostic and Therapeutics Price by Manufacturers
- 3.4 Exosome Diagnostic and Therapeutics Manufacturing Base Distribution, Product Types
- 3.4.1 Exosome Diagnostic and Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Exosome Diagnostic and Therapeutics Product Type
- 3.4.3 Date of International Manufacturers Enter into Exosome Diagnostic and Therapeutics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Exosome Diagnostic and Therapeutics Sales by Product
- 4.2 Global Exosome Diagnostic and Therapeutics Revenue by Product
- 4.3 Exosome Diagnostic and Therapeutics Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Exosome Diagnostic and Therapeutics Breakdown Data by End User
6 North America
- 6.1 North America Exosome Diagnostic and Therapeutics by Countries
- 6.1.1 North America Exosome Diagnostic and Therapeutics Sales by Countries
- 6.1.2 North America Exosome Diagnostic and Therapeutics Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Exosome Diagnostic and Therapeutics by Product
- 6.3 North America Exosome Diagnostic and Therapeutics by End User
7 Europe
- 7.1 Europe Exosome Diagnostic and Therapeutics by Countries
- 7.1.1 Europe Exosome Diagnostic and Therapeutics Sales by Countries
- 7.1.2 Europe Exosome Diagnostic and Therapeutics Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Exosome Diagnostic and Therapeutics by Product
- 7.3 Europe Exosome Diagnostic and Therapeutics by End User
8 Asia Pacific
- 8.1 Asia Pacific Exosome Diagnostic and Therapeutics by Countries
- 8.1.1 Asia Pacific Exosome Diagnostic and Therapeutics Sales by Countries
- 8.1.2 Asia Pacific Exosome Diagnostic and Therapeutics Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Exosome Diagnostic and Therapeutics by Product
- 8.3 Asia Pacific Exosome Diagnostic and Therapeutics by End User
9 Central & South America
- 9.1 Central & South America Exosome Diagnostic and Therapeutics by Countries
- 9.1.1 Central & South America Exosome Diagnostic and Therapeutics Sales by Countries
- 9.1.2 Central & South America Exosome Diagnostic and Therapeutics Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Exosome Diagnostic and Therapeutics by Product
- 9.3 Central & South America Exosome Diagnostic and Therapeutics by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Exosome Diagnostic and Therapeutics by Countries
- 10.1.1 Middle East and Africa Exosome Diagnostic and Therapeutics Sales by Countries
- 10.1.2 Middle East and Africa Exosome Diagnostic and Therapeutics Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Exosome Diagnostic and Therapeutics by Product
- 10.3 Middle East and Africa Exosome Diagnostic and Therapeutics by End User
11 Company Profiles
- 11.1 Thermo Fisher
- 11.1.1 Thermo Fisher Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Thermo Fisher Exosome Diagnostic and Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Thermo Fisher Exosome Diagnostic and Therapeutics Products Offered
- 11.1.5 Thermo Fisher Recent Development
- 11.2 NanoSomix
- 11.2.1 NanoSomix Company Details
- 11.2.2 Company Business Overview
- 11.2.3 NanoSomix Exosome Diagnostic and Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 NanoSomix Exosome Diagnostic and Therapeutics Products Offered
- 11.2.5 NanoSomix Recent Development
- 11.3 NX PHARMAGEN
- 11.3.1 NX PHARMAGEN Company Details
- 11.3.2 Company Business Overview
- 11.3.3 NX PHARMAGEN Exosome Diagnostic and Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 NX PHARMAGEN Exosome Diagnostic and Therapeutics Products Offered
- 11.3.5 NX PHARMAGEN Recent Development
- 11.4 Malvern
- 11.4.1 Malvern Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Malvern Exosome Diagnostic and Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Malvern Exosome Diagnostic and Therapeutics Products Offered
- 11.4.5 Malvern Recent Development
- 11.5 Capricor
- 11.5.1 Capricor Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Capricor Exosome Diagnostic and Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Capricor Exosome Diagnostic and Therapeutics Products Offered
- 11.5.5 Capricor Recent Development
- 11.6 Exosome
- 11.6.1 Exosome Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Exosome Exosome Diagnostic and Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Exosome Exosome Diagnostic and Therapeutics Products Offered
- 11.6.5 Exosome Recent Development
- 11.7 Exiqon
- 11.7.1 Exiqon Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Exiqon Exosome Diagnostic and Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Exiqon Exosome Diagnostic and Therapeutics Products Offered
- 11.7.5 Exiqon Recent Development
- 11.8 System Biosciences
- 11.8.1 System Biosciences Company Details
- 11.8.2 Company Business Overview
- 11.8.3 System Biosciences Exosome Diagnostic and Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 System Biosciences Exosome Diagnostic and Therapeutics Products Offered
- 11.8.5 System Biosciences Recent Development
- 11.9 Aegle
- 11.9.1 Aegle Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Aegle Exosome Diagnostic and Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Aegle Exosome Diagnostic and Therapeutics Products Offered
- 11.9.5 Aegle Recent Development
- 11.10 AMS
- 11.10.1 AMS Company Details
- 11.10.2 Company Business Overview
- 11.10.3 AMS Exosome Diagnostic and Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 AMS Exosome Diagnostic and Therapeutics Products Offered
- 11.10.5 AMS Recent Development
12 Future Forecast
- 12.1 Exosome Diagnostic and Therapeutics Market Forecast by Regions
- 12.1.1 Global Exosome Diagnostic and Therapeutics Sales Forecast by Regions 2019-2025
- 12.1.2 Global Exosome Diagnostic and Therapeutics Revenue Forecast by Regions 2019-2025
- 12.2 Exosome Diagnostic and Therapeutics Market Forecast by Product
- 12.2.1 Global Exosome Diagnostic and Therapeutics Sales Forecast by Product 2019-2025
- 12.2.2 Global Exosome Diagnostic and Therapeutics Revenue Forecast by Product 2019-2025
- 12.3 Exosome Diagnostic and Therapeutics Market Forecast by End User
- 12.4 North America Exosome Diagnostic and Therapeutics Forecast
- 12.5 Europe Exosome Diagnostic and Therapeutics Forecast
- 12.6 Asia Pacific Exosome Diagnostic and Therapeutics Forecast
- 12.7 Central & South America Exosome Diagnostic and Therapeutics Forecast
- 12.8 Middle East and Africa Exosome Diagnostic and Therapeutics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Exosome Diagnostic and Therapeutics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Exosome Diagnostic and Therapeutics . Industry analysis & Market Report on Exosome Diagnostic and Therapeutics is a syndicated market report, published as Global Exosome Diagnostic and Therapeutics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Exosome Diagnostic and Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
